Have any questions?
+44 1234 567 890
Kritika Garg, PhD
LEAD DEGENERATIVE DISC DISEASE R&D
Kritika leads GQ Bio’s degenerative disc disease project. She is responsible for GQ Bio’s internal research towards developing gene therapy drugs for the treatment of degenerative disc disease and manages the company’s proprietary ex vivo intervertebral disc screening platform.
Kritika was awarded a PhD in RNA molecular biology from the Université Libre de Bruxelles, Belgium, for her research on ribosomal modifications that influence translation. Prior to joining GQ Bio, she worked as a postdoctoral researcher in university hospital Bonn, Germany, on elucidating the immunological landscape of small cell lung cancer.